CTL IP Series 2: What is Patent Eligible in the U.S.?

For this second virtual meeting of the IP series, Dr. John D. Lopinski, Partner at Hodgson Russ LLP, will present an overview of patent-eligible subject matter and will provide some examples to illustrate issues related to patent eligibility.

Virtual

3/19/2021 from 12 pm to 1 pm (EST)
For this second virtual meeting of the IP series, Dr. John D. Lopinski, Partner at Hodgson Russ LLP, will present an overview of patent-eligible subject matter and will provide some examples to illustrate issues related to patent eligibility.

Dr. John D. Lopinski will be joined by Bill Pegg, Associate Director for IP at CTL.

Topics include:

Overview of patent-eligible subject matter
Challenges in obtaining patent eligibility in Life Sciences (e.g., Diagnostics, Antibodies, etc.)
Challenges in obtaining patent eligibility in Physical Sciences (e.g., Electronics, Encryption, Blockchain, Crypto, Software, etc.)

Speakers:

John D. Lopinski, Ph.D., Partner, Hodgson Russ LLP
Bill Pegg, Associate Director for IP, CTL